Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Treasury Shares: 2016-2025

Historic Treasury Shares for Collegium Pharmaceutical (COLL) over the last 5 years, with Sep 2025 value amounting to $222.5 million.

  • Collegium Pharmaceutical's Treasury Shares rose 29.08% to $222.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $222.5 million, marking a year-over-year increase of 29.08%. This contributed to the annual value of $197.5 million for FY2024, which is 43.76% up from last year.
  • Collegium Pharmaceutical's Treasury Shares amounted to $9.0 million in Q3 2025, which was up 1.46% from $8.9 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Treasury Shares ranged from a high of $9.0 million in Q3 2025 and a low of -$859,040 during Q3 2021.
  • Moreover, its 3-year median value for Treasury Shares was $7.2 million (2024), whereas its average is $6.6 million.
  • Data for Collegium Pharmaceutical's Treasury Shares shows a peak YoY soared of 210.54% (in 2022) over the last 5 years.
  • Over the past 5 years, Collegium Pharmaceutical's Treasury Shares (Quarterly) stood at $42.9 million in 2021, then spiked by 44.48% to $61.9 million in 2022, then skyrocketed by 121.85% to $137.4 million in 2023, then spiked by 43.76% to $197.5 million in 2024, then climbed by 29.08% to $222.5 million in 2025.
  • Its Treasury Shares stands at $222.5 million for Q3 2025, versus $217.5 million for Q2 2025 and $197.5 million for Q1 2025.